NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Air Force vet Terra Trujillo finds BioWork certificate brings new career options in transition to civilian life.
Durham-based Altis Biosystems is offering a research award of up to $10,000 for a scientific team to use its proprietary drug-development technology in a research project.
RTP's leading contract research organization IQVIA has just opened a new 160,000–square-foot lab facility for its Q2 Solutions subsidiary.
Morrisville-based Advanced Animal Diagnostics, a developer of rapid diagnostic and data systems for human and animal health, has been awarded a $733,000 federal contract to develop a system for the earlier detection of severe infection, including sepsis, in humans.
Though access to capital for women entrepreneurs is still a significant obstacle, Bank of America is hoping to change that.with a new capital directory.
Flu vaccine producer Seqirus will work with nearly $35 million in funding from the U.S. government to develop two vaccine candidates at its huge Holly Springs facility to combat future flu pandemics.
RedHill Biopharma, with U.S. headquarters in Raleigh, is reporting a 62% reduction in mortality for severe COVID-19 patients using its investigational oral pill-based therapy, opaganib.
People can now test simultaneously for COVID-19 and influenza in the safety of their own home using Labcorp’s newly approved test kit.
Cambrex Corp., a contract manufacturer of small-molecule therapeutics with major facilities in High Point and Durham, plans to invest another $30 million and hire 78 more employees to expand the production capabilities of its High Point campus.
Heard about career opportunities in NC's biopharma manufacturing field but want to know a little more before taking the leap? Here are the top 5 questions we’ve received at Bio Jobs Hub from people like you, with our answers.
UNC's CRISPR Genetic & Epigenetic Screening Center opens Oct. 1, with powerful new technology that received funding support from NCBiotech.
As I interviewed people who have completed the BioWork certification, and their instructors, I have learned a few things. If you have been thinking about making a career change, read on.
East Carolina University and the North Carolina Biotechnology Center are working together to bring new technologies to the marketplace.
Mayne Pharma has won an FDA OK for its topical corticosteroid LEXETTE to treat moderate to severe plaque psoriasis in patients 12 and older.
The Retinal Degeneration Fund is spinning out its own Raleigh-based biotech startup, Opus Genetics, aiming at curing blindness after landing $19 million in seed financing.
scroll back to top of page